Open house drug discount agreements Melatonin, excluding prolonged-release tablets in the strength of 2mg, ATC N05CH01
AOK Bayern - Die Gesundheitskasse, MünchenTED 713168-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Results
37,413 open tenders
CountryTenderValueClosesDays left
Open house pharmaceutical discount agreements Trastuzumab, for subcutaneous use, ATC L01FD01
AOK Bayern - Die Gesundheitskasse, MünchenTED 711308-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Open house pharmaceutical discount agreements Chlortalidone, ATC C03BA04
AOK Bayern - Die Gesundheitskasse, MünchenTED 711430-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Open house drug discount agreements Flupentixol, ATC N05AF01
AOK Bayern - Die Gesundheitskasse, MünchenTED 713987-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Open house drug discount agreements Rituximab, ATC L01FA01
AOK Bayern - Die Gesundheitskasse, MünchenTED 714205-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Open house drug discount agreements Pridinol, ATC M03BX03
AOK Bayern - Die Gesundheitskasse, MünchenTED 712813-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Open house pharmaceutical discount agreements Apixaban, ATC B01AF02
AOK Bayern - Die Gesundheitskasse, MünchenTED 712581-2026
value not stated1 lot
Tue 3 Oct12:00 in Berlin
704days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Glatiramer acetate (excluding pre-filled syringes), ATC L03AX13 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 713854-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Indacaterol + Glycopyrronium bromide, ATC R03AL04, for the period 01.12.2026 – 30.11.2028
DAK-Gesundheit, HamburgTED 712386-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Botulinum toxin type A (excluding Onabotulinum), ATC M03AX21 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 712558-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Botulinum toxin type A (exclusively Abobotulinum), ATC M03AX21 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 714096-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Ublituximab, ATC L04AG14 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 713501-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Cladribine, ATC L04AA40 for the period 01.12.2026 - 30.11.2027 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 714558-2026
€11 lot, 1 year
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Botulinum toxin type A (excluding Incobotulinum), ATC M03AX21 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 712509-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Natalizumab (infusion concentrate solution only), ATC L04AG03, for the period 01.12.2026 – 30.11.2028
DAK-Gesundheit, HamburgTED 712181-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Elafibranor, ATC A05AX06 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 714090-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
706days
Non-exclusive supply agreement with the possibility of conclusion at any time under the so-called Open-House procedure of the AOK Nordost
AOK Nordost - Die Gesundheitskasse, PotsdamTED 454539-2026
value not stated1 lot
Thu 5 Oct23:58 in Berlin
706days
Open framework agreement on drug discounts pursuant to § 130a para. 8 SGB V with the possibility of joining at any time, so-called admission model 2026-12
Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 720736-2026
value not stated6 lots
Thu 5 Oct23:59 in Berlin
706days
Open-House contracts 2026 - Aflibercept (Copy)
AOK Bremen/BremerhavenTED 663636-2026
value not stated1 lot
Thu 5 Oct23:59 in Berlin
706days
Open House "Teledermatology - New version 2026"
GWQ ServicePlus AG, DüsseldorfTED 642080-2026
value not stated1 lot, 2 years
Sun 15 Oct12:00 in Berlin
716days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.